Literature DB >> 18528890

Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological follow-up.

D Schledermann1, B T Andersen, K Bisgaard, M Dohse, D Ejersbo, B Hoelund, P Horal, M Lindh, W Ryd.   

Abstract

The objectives of the study were to evaluate 1) the diagnostic sensitivity and specificity of p16(INK4a) as a marker for high-grade cervical lesions, 2) the results of a real-time polymerase chain reaction detecting high-risk human papillomavirus, and 3) the interobserver variability of the p16(INK4a) interpretation.A total of 232 ThinPrep samples were stained for p16(INK4a), and HPV-DNA PCR was performed on 107 specimens with inclusion of both benign and abnormal cytology. Histological follow-up information was collected. The diagnostic sensitivity of ASC+ with CIN2+ in histology as endpoint was 96% for p16(INK4a) and 100% for HR-HPV DNA PCR, and the diagnostic specificity was 41% and 27%, respectively. If p16(INK4a) had been used for triage of the ASC samples, then 18 patients (42%) could have been spared unnecessary follow-up procedures compared to six patients (21%) with the HR-HPV DNA test. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528890     DOI: 10.1002/dc.20822

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

Review 1.  p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis.

Authors:  Jolien Roelens; Miriam Reuschenbach; Magnus von Knebel Doeberitz; Nicolas Wentzensen; Christine Bergeron; Marc Arbyn
Journal:  Cancer Cytopathol       Date:  2012-06-14       Impact factor: 5.284

2.  Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease.

Authors:  Ankica Lukic; Giorgio Sbenaglia; Elisabetta Carico; Matilde DI Properzio; Enrico Giarnieri; Antonio Frega; Flavia Nobili; Massimo Moscarini; Maria Rosaria Giovagnoli
Journal:  Exp Ther Med       Date:  2011-07-01       Impact factor: 2.447

3.  [Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia].

Authors:  P Ziemke; K Marquardt
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.